July 2026

10 new IVDR-compliant
qPCR assays

We’re proud to announce the certification of 10 new products under Regulation (EU) 2017/746 (IVDR), expanding our portfolio of fast, reliable, and compliant molecular diagnostic solutions for clinical laboratories.

Discover our complete IVDR-certified product portfolio and download the overview here: FRIZ Biochem – Lab direct qPCR

Our IVDR-certified portfolio now covers a broad range of applications, including:

🫁 Respiratory diagnostics
• res1plex–res6plex direct PCR/RT-PCR assays for bacterial and viral
respiratory pathogens
• COVID-19 direct RT-PCR for SARS-CoV-2 detection

🧪 Gastrointestinal diagnostics
• GastroBac, GastroVir1, GastroVir2, and Helicobacter direct PCR assays covering key bacterial, viral, and resistance targets

🏥 Hospital-acquired infections
• MRSA direct PCR for detection of methicillin-resistant and/or
vancomycin-resistant Staphylococcus aureus

Together with our previously certified res4plex direct RT-PCR and GastroBac direct PCR assays, these additions further strengthen our commitment to delivering innovative, IVDR-compliant molecular diagnostics.